Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XOMA 052 in Type 2 Diabetes on Metformin
NCT01144975Phase 2Completed
- Sponsor
- XOMA
- Start
- May 2010
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing XOMA 052 with Placebo (2 arms). Primary endpoint: Safety assessed by vital signs, laboratory assessments, and adverse events. Started May 2010; status: completed.
02
Drugs
gevokizumab
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01144975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144975.